ReviewHarm reduction journal2022

Opioid agonist treatment take-home doses ('carries'): Are current guidelines resulting in low treatment coverage among high-risk populations in Canada and the USA?

Cayley Russell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.